High-dose antioxidant therapy during thrombolysis in patients with acute myocardial infarction

Emanuele Altomare, Paolo Colonna, Carlo D'Agostino, Giustina Castellaneta, Gianluigi Vendemiale, Ignazio Grattagliano, Francesca Cirelli, Francesco Bovenzi, Luigi Colonna

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This study investigated the effects of 24-hour intravenous infusion of glutathione (GSH) on plasma malondialdehyde (MDA) levels and on clinical recovery after myocardial infarction in 67 patients treated with recombinant tissue-type plasminogen activator (rt-PA) and 29 patients not given rt-PA. Baseline MDA levels were also measured in 20 healthy control subjects matched for sex, age, and smoking habits. Administration of rt-PA resulted in an earlier recovery of ST elevation. A higher number of patients with fast ST recovery, a lower creatine phosphokinase (CPK) maximum peak, earlier CPK peak, and a lower incidence of arrhythmic episodes were among those who received GSH in addition to rt-PA. Patients who did not receive rt-PA showed a rather steady trend of plasma MDA levels. Patients receiving thrombolytic therapy showed increased MDA concentrations beginning 6 hours after starting therapy. However, while the patients treated only with rt-PA showed a continuous increase in MDA levels, those patients who also received GSH had a significant decrease in MDA levels. Plasma MDA levels significantly increased after thrombolysis; administration of GSH appeared to limit some adverse effects associated with reperfusion-induced oxidative stress.

Original languageEnglish
Pages (from-to)131-141
Number of pages11
JournalCurrent Therapeutic Research
Volume57
Issue number2
DOIs
Publication statusPublished - 1996

Fingerprint

Malondialdehyde
Tissue Plasminogen Activator
Antioxidants
Myocardial Infarction
Creatine Kinase
Therapeutics
Thrombolytic Therapy
Intravenous Infusions
Habits
Reperfusion
Glutathione
Healthy Volunteers
Oxidative Stress
Smoking
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Altomare, E., Colonna, P., D'Agostino, C., Castellaneta, G., Vendemiale, G., Grattagliano, I., ... Colonna, L. (1996). High-dose antioxidant therapy during thrombolysis in patients with acute myocardial infarction. Current Therapeutic Research, 57(2), 131-141. https://doi.org/10.1016/S0011-393X(96)80007-5

High-dose antioxidant therapy during thrombolysis in patients with acute myocardial infarction. / Altomare, Emanuele; Colonna, Paolo; D'Agostino, Carlo; Castellaneta, Giustina; Vendemiale, Gianluigi; Grattagliano, Ignazio; Cirelli, Francesca; Bovenzi, Francesco; Colonna, Luigi.

In: Current Therapeutic Research, Vol. 57, No. 2, 1996, p. 131-141.

Research output: Contribution to journalArticle

Altomare, E, Colonna, P, D'Agostino, C, Castellaneta, G, Vendemiale, G, Grattagliano, I, Cirelli, F, Bovenzi, F & Colonna, L 1996, 'High-dose antioxidant therapy during thrombolysis in patients with acute myocardial infarction', Current Therapeutic Research, vol. 57, no. 2, pp. 131-141. https://doi.org/10.1016/S0011-393X(96)80007-5
Altomare E, Colonna P, D'Agostino C, Castellaneta G, Vendemiale G, Grattagliano I et al. High-dose antioxidant therapy during thrombolysis in patients with acute myocardial infarction. Current Therapeutic Research. 1996;57(2):131-141. https://doi.org/10.1016/S0011-393X(96)80007-5
Altomare, Emanuele ; Colonna, Paolo ; D'Agostino, Carlo ; Castellaneta, Giustina ; Vendemiale, Gianluigi ; Grattagliano, Ignazio ; Cirelli, Francesca ; Bovenzi, Francesco ; Colonna, Luigi. / High-dose antioxidant therapy during thrombolysis in patients with acute myocardial infarction. In: Current Therapeutic Research. 1996 ; Vol. 57, No. 2. pp. 131-141.
@article{ff94b8164b2545cda97403ba1b093e74,
title = "High-dose antioxidant therapy during thrombolysis in patients with acute myocardial infarction",
abstract = "This study investigated the effects of 24-hour intravenous infusion of glutathione (GSH) on plasma malondialdehyde (MDA) levels and on clinical recovery after myocardial infarction in 67 patients treated with recombinant tissue-type plasminogen activator (rt-PA) and 29 patients not given rt-PA. Baseline MDA levels were also measured in 20 healthy control subjects matched for sex, age, and smoking habits. Administration of rt-PA resulted in an earlier recovery of ST elevation. A higher number of patients with fast ST recovery, a lower creatine phosphokinase (CPK) maximum peak, earlier CPK peak, and a lower incidence of arrhythmic episodes were among those who received GSH in addition to rt-PA. Patients who did not receive rt-PA showed a rather steady trend of plasma MDA levels. Patients receiving thrombolytic therapy showed increased MDA concentrations beginning 6 hours after starting therapy. However, while the patients treated only with rt-PA showed a continuous increase in MDA levels, those patients who also received GSH had a significant decrease in MDA levels. Plasma MDA levels significantly increased after thrombolysis; administration of GSH appeared to limit some adverse effects associated with reperfusion-induced oxidative stress.",
author = "Emanuele Altomare and Paolo Colonna and Carlo D'Agostino and Giustina Castellaneta and Gianluigi Vendemiale and Ignazio Grattagliano and Francesca Cirelli and Francesco Bovenzi and Luigi Colonna",
year = "1996",
doi = "10.1016/S0011-393X(96)80007-5",
language = "English",
volume = "57",
pages = "131--141",
journal = "Current Therapeutic Research - Clinical and Experimental",
issn = "0011-393X",
publisher = "Excerpta Medica",
number = "2",

}

TY - JOUR

T1 - High-dose antioxidant therapy during thrombolysis in patients with acute myocardial infarction

AU - Altomare, Emanuele

AU - Colonna, Paolo

AU - D'Agostino, Carlo

AU - Castellaneta, Giustina

AU - Vendemiale, Gianluigi

AU - Grattagliano, Ignazio

AU - Cirelli, Francesca

AU - Bovenzi, Francesco

AU - Colonna, Luigi

PY - 1996

Y1 - 1996

N2 - This study investigated the effects of 24-hour intravenous infusion of glutathione (GSH) on plasma malondialdehyde (MDA) levels and on clinical recovery after myocardial infarction in 67 patients treated with recombinant tissue-type plasminogen activator (rt-PA) and 29 patients not given rt-PA. Baseline MDA levels were also measured in 20 healthy control subjects matched for sex, age, and smoking habits. Administration of rt-PA resulted in an earlier recovery of ST elevation. A higher number of patients with fast ST recovery, a lower creatine phosphokinase (CPK) maximum peak, earlier CPK peak, and a lower incidence of arrhythmic episodes were among those who received GSH in addition to rt-PA. Patients who did not receive rt-PA showed a rather steady trend of plasma MDA levels. Patients receiving thrombolytic therapy showed increased MDA concentrations beginning 6 hours after starting therapy. However, while the patients treated only with rt-PA showed a continuous increase in MDA levels, those patients who also received GSH had a significant decrease in MDA levels. Plasma MDA levels significantly increased after thrombolysis; administration of GSH appeared to limit some adverse effects associated with reperfusion-induced oxidative stress.

AB - This study investigated the effects of 24-hour intravenous infusion of glutathione (GSH) on plasma malondialdehyde (MDA) levels and on clinical recovery after myocardial infarction in 67 patients treated with recombinant tissue-type plasminogen activator (rt-PA) and 29 patients not given rt-PA. Baseline MDA levels were also measured in 20 healthy control subjects matched for sex, age, and smoking habits. Administration of rt-PA resulted in an earlier recovery of ST elevation. A higher number of patients with fast ST recovery, a lower creatine phosphokinase (CPK) maximum peak, earlier CPK peak, and a lower incidence of arrhythmic episodes were among those who received GSH in addition to rt-PA. Patients who did not receive rt-PA showed a rather steady trend of plasma MDA levels. Patients receiving thrombolytic therapy showed increased MDA concentrations beginning 6 hours after starting therapy. However, while the patients treated only with rt-PA showed a continuous increase in MDA levels, those patients who also received GSH had a significant decrease in MDA levels. Plasma MDA levels significantly increased after thrombolysis; administration of GSH appeared to limit some adverse effects associated with reperfusion-induced oxidative stress.

UR - http://www.scopus.com/inward/record.url?scp=0029975907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029975907&partnerID=8YFLogxK

U2 - 10.1016/S0011-393X(96)80007-5

DO - 10.1016/S0011-393X(96)80007-5

M3 - Article

VL - 57

SP - 131

EP - 141

JO - Current Therapeutic Research - Clinical and Experimental

JF - Current Therapeutic Research - Clinical and Experimental

SN - 0011-393X

IS - 2

ER -